Skip to main content
. 2022 Jun 12;12(6):962. doi: 10.3390/jpm12060962

Table 5.

Multivariate analysis of the prognostic factors of cancer-specific survival in patients with stage II/III gastric cancer.

Factors Hazard
Ratio
95% Confidence Interval p Value
Lower Upper
Type of gastrectomy
Total/partial 1.149 0.999 1.320 0.051
Tumor size (cm)
2.41–3.9/≤2.4 1.189 0.927 1.525 0.173
3.91–9.4/2.4 1.439 1.142 1.813 0.002
>9.4/≤2.4 1.692 1.254 2.282 <0.001
Stage (AJCC eighth edition)
IIB/IIA 1.558 1.075 2.259 0.019
IIIA/IIA 1.796 1.249 2.583 0.002
IIIB/IIA 2.082 1.396 3.106 <0.001
IIIC/IIA 2.357 1.535 3.619 <0.001
LN ratio
0.051–0.15/≤0.05 1.547 1.201 1.993 <0.001
0.151–0.37/≤0.05 2.249 1.728 2.928 <0.001
0.371–0.53/≤0.05 2.943 2.145 4.039 <0.001
>0.53/≤0.05 4.331 3.114 6.024 <0.001
Histological type
Differentiated/undifferentiated 1.058 0.921 1.215 0.427
Vascular invasion
Yes/no 1.062 0.906 1.243 0.459
Lymphatic invasion
Yes/no 1.168 0.969 1.408 0.104
Perineural invasion
Yes/no 1.231 1.066 1.421 0.005

AJCC—American Joint Committee on Cancer; LN ratio—metastatic to examined lymph node ratio.